• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的低钠血症

Hyponatremia in heart failure.

作者信息

Farmakis Dimitrios, Filippatos Gerasimos, Parissis John, Kremastinos Dimitrios Th, Gheorghiade Mihai

机构信息

Second Department of Cardiology, Heart Failure Unit, Attikon University Hospital, Athens, Greece.

出版信息

Heart Fail Rev. 2009 Jun;14(2):59-63. doi: 10.1007/s10741-008-9109-7. Epub 2008 Aug 29.

DOI:10.1007/s10741-008-9109-7
PMID:18758941
Abstract

Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with heart failure. It may occur in patients who have hypovolemic, hypervolemic, or euvolemic state. It is usually not corrected by available therapies. It is a major predictor of prognosis, and correction of hyponatremia can be effectively accomplished by vasopressin antagonists. However, it still remains to be seen whether the normalization of serum sodium with vasopressin antagonists will also lead to an improved long-term prognosis.

摘要

低钠血症是心力衰竭住院患者中最常见的电解质异常。它可能发生在低血容量、高血容量或血容量正常的患者中。现有治疗方法通常无法纠正这种情况。它是预后的主要预测指标,血管加压素拮抗剂可有效纠正低钠血症。然而,血管加压素拮抗剂使血清钠正常化是否也会改善长期预后仍有待观察。

相似文献

1
Hyponatremia in heart failure.心力衰竭中的低钠血症
Heart Fail Rev. 2009 Jun;14(2):59-63. doi: 10.1007/s10741-008-9109-7. Epub 2008 Aug 29.
2
Introduction: Vasopressin therapy.引言:血管加压素疗法。
Heart Fail Rev. 2009 Jun;14(2):57-8. doi: 10.1007/s10741-008-9116-8. Epub 2008 Nov 7.
3
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.托伐普坦治疗心力衰竭、肝硬化或抗利尿激素不适当分泌综合征伴高容量或正常容量性低钠血症:临床综述。
Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015.
4
Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.住院低钠血症患者对利尿剂托伐普坦的血清和尿液反应。
Int Urol Nephrol. 2012 Jun;44(3):865-71. doi: 10.1007/s11255-011-9996-8. Epub 2011 May 24.
5
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.急性失代偿性心力衰竭中的低钠血症:机制、预后和治疗选择。
Clin Cardiol. 2010 Nov;33(11):666-71. doi: 10.1002/clc.20822.
6
Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.血清钠浓度及托伐普坦治疗对心力衰竭患者住院时间的影响。
Am J Health Syst Pharm. 2011 Feb 15;68(4):328-33. doi: 10.2146/ajhp100217.
7
Correction of hyponatremia by tolvaptan before left ventricular assist device implantation.在植入左心室辅助装置前使用托伐普坦纠正低钠血症。
Int Heart J. 2012;53(6):391-3. doi: 10.1536/ihj.53.391.
8
[Etiology, diagnostics and therapy of hyponatremias].[低钠血症的病因、诊断与治疗]
Orv Hetil. 2008 Jul 20;149(29):1347-54. doi: 10.1556/OH.2008.28409.
9
Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.托伐普坦在因慢性心力衰竭加重伴严重低钠血症住院患者中的应用:土耳其一家单中心的初步经验。
Turk Kardiyol Dern Ars. 2017 Jul;45(5):415-425. doi: 10.5543/tkda.2017.80026.
10
AVP receptor antagonists in patients with CHF.充血性心力衰竭患者中的血管加压素受体拮抗剂
Heart Fail Rev. 2009 Jun;14(2):83-6. doi: 10.1007/s10741-008-9107-9. Epub 2008 Sep 3.

引用本文的文献

1
Impact of hypotonic hyponatremia on outcomes in patients undergoing transcatheter aortic valve replacement: a national inpatient sample.低渗性低钠血症对接受经导管主动脉瓣置换术患者预后的影响:一项全国住院患者样本研究
BMC Cardiovasc Disord. 2025 Mar 10;25(1):168. doi: 10.1186/s12872-025-04564-4.
2
Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case-control study.老年髋部骨折患者围手术期心房颤动的预测因素及预后:一项巢式病例对照研究。
BMC Geriatr. 2025 Jan 3;25(1):4. doi: 10.1186/s12877-024-05647-1.
3
The nonpathogenic role of hyponatremia in the onset of osteoporosis: A Mendelian randomization study.

本文引用的文献

1
Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.因心力衰竭加重住院期间低钠血症的改善与预后改善相关:来自血管加压素拮抗剂在慢性心力衰竭中的急性和慢性治疗影响(ACTIV in CHF)试验的见解。
Acute Card Care. 2007;9(2):82-6. doi: 10.1080/17482940701210179.
2
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.口服血管加压素拮抗剂托伐普坦对因心力衰竭住院患者的短期临床疗效:EVEREST临床状态试验
JAMA. 2007 Mar 28;297(12):1332-43. doi: 10.1001/jama.297.12.1332. Epub 2007 Mar 25.
3
低钠血症在骨质疏松症发病中的非致病作用:一项孟德尔随机化研究。
Medicine (Baltimore). 2024 Dec 13;103(50):e40876. doi: 10.1097/MD.0000000000040876.
4
Thalamic Neuron Resilience during Osmotic Demyelination Syndrome (ODS) Is Revealed by Primary Cilium Outgrowth and ADP-ribosylation factor-like protein 13B Labeling in Axon Initial Segment.原发性纤毛生长和轴突起始段 ADP-核糖基化因子样蛋白 13B 标记揭示渗透性脱髓鞘综合征(ODS)期间丘脑神经元的恢复能力。
Int J Mol Sci. 2023 Nov 17;24(22):16448. doi: 10.3390/ijms242216448.
5
Worsening renal function in hospitalized patients with systolic heart failure: prevalence and risk factors.收缩性心力衰竭住院患者肾功能恶化:患病率及危险因素
ESC Heart Fail. 2023 Oct;10(5):2837-2842. doi: 10.1002/ehf2.14463. Epub 2023 Jul 5.
6
Hyponatremia and lower normal serum sodium levels are associated with an increased risk of all-cause death in heart failure patients.低钠血症和正常血清钠水平降低与心力衰竭患者全因死亡风险增加相关。
Nurs Open. 2023 Jun;10(6):3799-3809. doi: 10.1002/nop2.1638. Epub 2023 Mar 16.
7
Ventricular longitudinal function by cardiovascular magnetic resonance predicts cardiovascular morbidity in HFrEF patients.心血管磁共振评估左心室纵向功能可预测 HFrEF 患者的心血管发病率。
ESC Heart Fail. 2022 Aug;9(4):2313-2324. doi: 10.1002/ehf2.13916. Epub 2022 Apr 11.
8
Role of Sodium Levels on Atrial Fibrillation in Heart Failure: Active Player or a Bystander?钠水平对心力衰竭中房颤的作用:主动参与者还是旁观者?
Arq Bras Cardiol. 2022 Apr;118(4):712-718. doi: 10.36660/abc.20210139.
9
Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report.低剂量托伐普坦诱发难治性心力衰竭患者高钠血症:一例报告
Medicine (Baltimore). 2019 Jul;98(27):e16229. doi: 10.1097/MD.0000000000016229.
10
Serial sodium values and adverse outcomes in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者的连续钠值与不良结局。
Int J Cardiol. 2019 Sep 1;290:119-124. doi: 10.1016/j.ijcard.2019.03.040. Epub 2019 Mar 22.
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.口服托伐普坦对因心力衰竭加重而住院患者的影响:EVEREST结局试验
JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319. Epub 2007 Mar 25.
4
Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.低钠血症、精氨酸加压素调节异常与加压素受体拮抗作用。
Am J Nephrol. 2006;26(6):579-89. doi: 10.1159/000098028. Epub 2006 Dec 14.
5
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.托伐普坦,一种选择性口服血管加压素V2受体拮抗剂,用于治疗低钠血症。
N Engl J Med. 2006 Nov 16;355(20):2099-112. doi: 10.1056/NEJMoa065181. Epub 2006 Nov 14.
6
Vaptans and the treatment of water-retaining disorders.
Semin Nephrol. 2006 May;26(3):234-43. doi: 10.1016/j.semnephrol.2006.02.003.
7
Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.口服非肽类选择性V2受体血管加压素拮抗剂利希普坦对纽约心脏协会心功能II级和III级慢性心力衰竭患者的利水作用。
J Am Coll Cardiol. 2006 Apr 18;47(8):1615-21. doi: 10.1016/j.jacc.2005.11.071. Epub 2006 Mar 29.
8
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.口服考尼伐坦的疗效与安全性:一种V1A/V2血管加压素受体拮抗剂,在等容性或高容性低钠血症患者中进行的随机、安慰剂对照试验评估
J Clin Endocrinol Metab. 2006 Jun;91(6):2145-52. doi: 10.1210/jc.2005-2287. Epub 2006 Mar 7.
9
Hyponatremia in patients with heart failure.心力衰竭患者的低钠血症
Am J Cardiol. 2005 Dec 19;96(12A):19L-23L. doi: 10.1016/j.amjcard.2005.09.066. Epub 2005 Oct 5.
10
Hyponatremia and heart failure--pathophysiology and implications.低钠血症与心力衰竭——病理生理学及影响
Congest Heart Fail. 2005 Sep-Oct;11(5):274-7. doi: 10.1111/j.1527-5299.2005.04180.x.